Can Fluprevli (cell‑culture trivalent influenza vaccine) be administered to pregnant or lactating patients who have an egg allergy?

Can Flucelvax (Cell-Culture Influenza Vaccine) Be Given to Pregnant, Breastfeeding, and Egg-Allergic Patients?

Yes, Flucelvax (ccIIV3) can be safely administered to pregnant women, breastfeeding mothers, and patients with egg allergy, including those with severe egg allergy or anaphylaxis to eggs.

Egg Allergy: No Longer a Barrier

The most recent ACIP guidelines (2025) explicitly state that all persons aged ≥6 months with egg allergy should receive influenza vaccine and that any influenza vaccine (egg-based or non-egg based) that is otherwise appropriate for the recipient's age and health status can be used 1. This is critical because:

• Flucelvax is a cell-culture based vaccine (ccIIV3) manufactured without eggs, making it an ideal choice for egg-allergic patients 2
• Even though egg-based vaccines have a labeled contraindication for egg allergy, ACIP recommendations override this labeling concern 1
• Multiple studies demonstrate that egg-allergic patients, even those with severe anaphylaxis to eggs, can safely receive influenza vaccines 3, 4

Key Point on Administration

You do not need to perform skin testing or use graded dosing protocols. The vaccine can be given as a single full dose in the standard clinical setting 3. There is no need to ask about egg allergy on screening forms before influenza vaccination 3.

Pregnancy: Safe and Recommended

Influenza vaccination is recommended for all pregnant women during any trimester to protect both mother and infant from influenza complications, which carry significant morbidity and mortality risks during pregnancy.

• VAERS surveillance data (2013-2020) of 391 pregnant women who received cell-culture influenza vaccine showed only 6.1% serious adverse events, with no maternal deaths 5
• The most common pregnancy-specific events were premature delivery (21.7%), which occurs at baseline in the general pregnant population 5
• The safety profile was consistent with other influenza vaccines used in pregnancy 5

The benefits of preventing influenza during pregnancy—which can cause severe maternal illness, hospitalization, and adverse fetal outcomes—far outweigh any theoretical vaccine risks.

Breastfeeding: Safe

Inactivated influenza vaccines like Flucelvax pose no risk to breastfeeding infants. The vaccine is not live-attenuated and cannot be transmitted through breast milk. Standard ACIP recommendations support influenza vaccination during lactation without any special precautions.

Contraindications to Watch For

The only true contraindications to Flucelvax are:

• Severe allergic reaction (anaphylaxis) to any previous dose of ccIIV of any valency 2
• Severe allergic reaction to any component of the specific vaccine (check package insert for components) 2

Important Caveat

If a patient had anaphylaxis to a different type of influenza vaccine (egg-based IIV, RIV, or LAIV), this is only a precaution (not contraindication) for ccIIV3 2. In this scenario, you can still administer Flucelvax, but do so in a medical setting where you can recognize and manage severe allergic reactions, with supervision by a provider capable of treating anaphylaxis 2.

Clinical Algorithm

For egg-allergic patients (including severe/anaphylaxis):

1. Confirm no history of anaphylaxis to ccIIV specifically
2. Administer full dose of Flucelvax without skin testing or graded dosing
3. Observe for 15-30 minutes post-vaccination (standard practice)

For pregnant patients:

1. Administer during any trimester
2. Use standard dosing and administration
3. No special precautions needed beyond routine vaccine administration

For breastfeeding patients:

1. Administer without restriction
2. Continue breastfeeding normally

For patients with prior anaphylaxis to other influenza vaccines:

1. Consider Flucelvax as an alternative option
2. Administer in medical setting with anaphylaxis management capability
3. Consider allergist consultation to identify the responsible component 2

Common Pitfalls to Avoid

• Do not withhold influenza vaccine from egg-allergic patients—this outdated practice increases their risk of influenza complications
• Do not require skin testing before vaccination—current evidence shows this is unnecessary 3
• Do not defer vaccination in pregnant women—influenza poses serious risks during pregnancy that vaccination prevents
• Do not confuse precautions with contraindications—a precaution means weigh risks/benefits and potentially proceed with monitoring, not automatic avoidance

The evidence strongly supports that Flucelvax is safe and should be administered to these populations to prevent influenza-related morbidity and mortality.